v3.26.1
Shareholders’ Equity (Deficit)
 6 Months Ended
Apr. 30, 2026
Equity [Abstract]  
Shareholders’ Equity (Deficit)

NOTE 7 - Shareholders’ Equity (Deficit)

 

Ordinary shares - The Company is authorized to issue a total of 500,000,000 ordinary shares at par value of $0.0001 each. As of April 30, 2026 and October 31, 2025, there were 4,694,069 and 4,362,069 shares issued and outstanding ordinary shares, excluding 11,200,000 shares subject to possible redemption.

 

Rights - Each holder of a right will receive one-fifth (1/5) ordinary share upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange of the rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination as the consideration related thereto has been included in the Unit purchase price paid for by investors in the Initial Public Offering. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary share basis and each holder of a right will be required to affirmatively convert its rights in order to receive 1/5 share underlying each right (without paying additional consideration). The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company).